William R Spreen Selected Research

Integrase Inhibitors

1/2019

A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Patients With Hepatic Impairment and Healthy Matched Controls.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William R Spreen Research Topics

Disease

15	Infections 01/2022 - 03/2004
5	Injection Site Reaction 01/2022 - 01/2017
4	Pain (Aches) 01/2020 - 01/2017
3	Hypersensitivity (Allergy) 02/2009 - 03/2004
2	HIV Infections (HIV Infection) 01/2022 - 01/2017
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2022
1	Syphilis 01/2022
1	Fatigue 11/2021
1	Viremia 01/2015
1	Drug-Related Side Effects and Adverse Reactions 02/2009

Drug/Important Bio-Agent (IBA)

15	cabotegravirIBA 01/2022 - 03/2014
7	Rilpivirine (TMC-278)IBA 11/2021 - 10/2015
3	Pharmaceutical PreparationsIBA 01/2022 - 03/2004
3	abacavir (Ziagen)FDA Link 02/2009 - 03/2004
2	HLA-B Antigens (HLA-B)IBA 11/2004 - 03/2004
1	RacivirIBA 01/2022
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2022
1	Contraceptive Agents (Contraceptives)IBA 01/2022
1	N,N-dimethyl-4-anisidine (DMPA)IBA 01/2022
1	dolutegravirIBA 01/2020
1	lamivudine drug combination abacavir FDA Link 01/2020
1	Integrase InhibitorsIBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2017
1	Human immunodeficiency virus 1 p31 integrase proteinIBA 01/2017
1	NucleosidesIBA 10/2015
1	Reverse Transcriptase InhibitorsIBA 10/2015
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2004

Therapy/Procedure

7	Injections 01/2022 - 10/2015
4	Therapeutics 11/2021 - 01/2020
1	Contraception (Birth Control) 01/2022
1	Blood Transfusion (Blood Transfusions) 01/2017